chrisvoncsefalvay/vaers-outcomes huggingface dataset:
? 1st dose Pfizer was on 04/29/21, 2nd 05/20/21. Patient was only 15yrs old at the time of first dose.  Just reporting the age of the patient at the time of their first dose. No adverse effects
Systemic: Fainting / Unresponsive-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Nausea-Mild, Additional Details: pt felt like she was having a panic attack at first. She had been nervous about shot but did not feel panic feeling until was waiting her 15min after shot, took mask off, drank some water and tried to breath to relax. noticed her putting head down. she felt faint & nauseous. did not vomit, but did pass out. we lowered her to ground, elevated feet. came to right away but still clamy. eventually she sat up with cool compresses to forehead. waited on paramedics. did not go w paramedics.
testing positive initially on 15Jun2022; testing positive initially on 15Jun2022; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 27May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 37 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Jun2022, outcome "not recovered" and all described as "testing positive initially on 15Jun2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Jun2022) Positive; (29Jun2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Other medication in two weeks was no, anti-viral details product=COVID 19 Treatment, if treatment adverse event no.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt with elevated papules on dorsal and plantar surface of hand and feet with some vesicles and bulla. Severely prurutic. Prednisone.
Left bicep pain and swelling after receiving a pneumonia vaccine yesterday. He reports having temp of 105 today and had nausea and vomiting before leaving the hospital. This am woke up at 5am with h/a, nausea, vomited x 1, not able to tolerate po, felt achy all over, and had mild shivers. Temp at home 105 degrees F. No cough, no known sick contacts, no out of state travel, works office job. Had slight chest pressure and SOB on arrival to ER, this has since resolved.
COVID19 (moderna) Shot was taken at 11:00 in the left arm on Saturday Feb 27  At 5:00 PM On Feb 27 my left eye began having black swirlies.  They were like black strings.  I have NEVER had swirlies in my life.  At 8:00 PM Feb 27 on top of the swirlies that had moved to my peripheral vision left side of the left eye, I began having bright flashes like lightening.  On Sunday  Feb 28 the swirlies stayed just as peripheral vision and the bright flashes were noticed more in the late evening.   Today March 1 they are still there and were more noticeable as I was driving to work.  As I am typing this the swirlie moves from the center to the left side of the eye.
patient had vasovagal episode immediatly after receiving the vaccination, there was vomiting associated with the episode. Patient vitals remained stable, he was observed for 30 minutes, given juice, water and crackers and able to ambulate without difficulty. Vitals remained stable.
immediately felt soreness in her left arm and also there was pain if she tried to raise her arm; developed a low grade fever, up 1 degree from her usual temperature; became dizzy; extremely tired; slept off and on; had a heavy head; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 68-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot number was not reported) via an unspecified route of administration, administered in left arm on an unspecified date in Feb2021 at 10:45 AM (at the age of 68-years-old) as dose 1, single dose for covid-19 immunisation. The patient's medical history included type 2 diabetes mellitus, sulfa drugs allergy and shellfish allergy from an unknown date and unknown if ongoing. The patient previously took codeine and experienced bad reaction to codeine. The patient's concomitant medications were not reported. Patient didn't got covid prior to vaccination. Patient not tested for covid-19 post vaccination. On unspecified date in Feb 2021 at 10:45 AM, after receiving the shot patient immediately felt soreness in her left arm and also there was pain if she tried to raise her arm. Approximately 9-10 hours after receiving the shot patient became dizzy, extremely tired, slept off and on and during the third day, patient developed a low-grade fever, up 1 degree from her usual temperature and on fourth day patient had a heavy head. Patient also reported that she was not as tired, the left arm soreness was all but gone, and she was no longer dizzy. soreness in her left arm, and all of these symptoms lasted for 72 hours. The patient did not receive any treatment for the adverse events. The outcome of all events was recovered on unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
no adverse effect reported; Received an expired dose of Vaqta; This spontaneous report was received from a pharmacist and refers to a 4 year old patient. The patient's medical history, concurrent conditions and concomitant therapies were not provided.    On 15-OCT-2019, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated(VAQTA) lot # R024007, expiration date on 12-OCT-2019, for prophylaxis (strength, dosage, frequency and route were not reported) (expired product administered). No adverse effects were reported.
Patient felt  dizzy right after her vaccination, she was sweating a lot and  wanted to throw up but didn't  . No problem breathing .  we called 911 and ambulance came and took patient to hospital for further evaluation.  we called patient's dad at 3:00 pm, patient was feeling fine and got home already.
no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 23-month-old patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 08-JAN-2021, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) lot # T013204, expiration date was not provided, but upon internal validation process it was established as 03-DEC-2021 (dose, route of administration and anatomical location were not provided) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 47.01 Fahrenheit (F) for 1 minute 30 seconds. Data logger was involved. There were no previous excursions reported. No additional adverse events were reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2102USA003923: US-009507513-2102USA004059:
I have had nonstop headaches since post vaccine day 6; Tylenol ibuprofen and aspirin do not help it, the meds just minimize it.  The headaches move all over my head they?re not in one place.  They?re all day long. I?m hoping they?ll go away soon. It?s been 11 days now with this. I?m also having some orthostatic BP dizziness.
Headache, Myalgia, Arthralgia, chills,fatigue; Narrative:
Onset of left sided facial droop, tongue heaviness / loss of sensation, acute cortical stroke.
C/o redness, itching, swelling. Started 9/22/10 & has gradually gotten worse. Large red area (L) upper arm 15cm x 22cm with itchy borders. Hot to touch. Noted 9/27/10.
Delayed rash/hives one day after getting vaccine. Hives appeared in three areas on lower back, one area on front, just below right breast, rash on left upper thigh in front, and one rash spot on left leg behind knee. Rash areas itched and were treated with hydrocortisone cream applied twice during evening. The next morning the rash, hives and itching were gone.
Initial report received on 24 January 2013 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a 13-month-old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDS) electronic database. The subject had received 3 doses of PENTACEL; Dose 1 received on 19 January 2012 (lot number not reported),  lot number C4131AA received on 17 May 2012, and lot number C4259AA received on 23 August 2012 (routes and sites of administration not reported). The subject developed a cough on 04 January 2013, approximately 134 days after the last dose, and a paroxysmal cough with a whoop on 12 January 2013. The subject also developed cold like symptoms on 14 December 2012 and apnea (start date not reported). Laboratory testing included positive PCR on 11 January 2013. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 11 January 2013 for 5 days. The subject was not hospitalized. At the time of final contact on 18 January 2013, the subject's cough was still persisting. The duration of the cough was reported at that time as 14 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
No adverse event; The dose was 0.25ml/ Dose 0.25ml administered instead of a 0.5ml dose/ Invalid bivalent dose adminstered; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (The dose was 0.25ml/ Dose 0.25ml administered instead of a 0.5ml dose/ Invalid bivalent dose adminstered) and NO ADVERSE EVENT (No adverse event) in a 19-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 15-Sep-2022, the patient experienced ACCIDENTAL UNDERDOSE (The dose was 0.25ml/ Dose 0.25ml administered instead of a 0.5ml dose/ Invalid bivalent dose adminstered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (The dose was 0.25ml/ Dose 0.25ml administered instead of a 0.5ml dose/ Invalid bivalent dose adminstered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered ACCIDENTAL UNDERDOSE (The dose was 0.25ml/ Dose 0.25ml administered instead of a 0.5ml dose/ Invalid bivalent dose adminstered) and NO ADVERSE EVENT (No adverse event) to be not related.    Concomitant product use was not provided by the reporter. Patient did not have any known drug allergy. The patient was called on 28-Sep-2022 and Patient was informed for the dosing error.  Reporter also stated that 2.5 ml was administered but the administration error was 0.25 ml. Patient made aware received a 0.25 mL of Moderna Bivalent Booster dose. Patient verbalized understanding. Patient denies having distress currently. Patient denied having to go to the Emergency room or Primary Care provider. It has been also informed to patient that according to Moderna the recommendation was to re vaccinate with full dose in 8 weeks from 15-Sep-2022. Patient stated would like to be re vaccinate. Treatment information was not provided.
Late afternoon 10/8/99, pt experienced fatigue, lethargy, anorexia, no HA, fever, muscle aches, nausea/vomiting, by 10/10 had developed a rash that was patchy and raised on legs, chest, back face, it was intensely itchy.
The patient was given 2 doses of the fluad along with the Abrysvo.  No treatment was required and the patient did not experience any discomfort or adverse signs/symptoms.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. On 16-SEP-2013 the patient was vaccinated with a dose of PNEUMOVAX23 (lot # J004747, expiration date 20-JUL-2014, dose unspecified) subcutaneous in the tricep muscle of left arm. Other suspect therapies included FLUVIRIN in the same arm. In September 2013 the patient experienced injection site reaction after vaccination with PNEUMOVAX23. It was unknown if this was the patient's first vaccination with PNEUMOVAX23. The patient was diagnosed with cellulitis. The patient sought medical attention via contacted physician. Unspecified antibiotic was given for treatment. The event outcome was reported as not recovered. Additional information has been requested.
Pins and needles sensation started in left hand then left arm, right foot, and began intermittently to all parts of the body. I was told by PCP to take 600 mg Ibuprofen three times a day for a few days to see if that would eliminate it. It does help the sensation subside, but when Ibuprofen wears off  pins and needles sensation returns.
SEVERE BODY ACHES ON LEFT SIDE; MUSCLE SPASMS ON LEFT SIDE LEG EYE ARM AND CRAMPING ON RIGHT SIDE; PRESSURE BEHIND LEFT EYE; CRAMPING AND RIB PAIN ON RIGHT SIDE; This spontaneous report received from a patient via a company representative concerned a 52 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no underline health problems. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 30-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced pressure behind left eye. On 2021, the subject experienced cramping and rib pain on right side. On 30-APR-2021, the subject experienced severe body aches on left side. On 30-APR-2021, the subject experienced muscle spasms on left side leg eye arm and cramping on right side. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from severe body aches on left side, muscle spasms on left side leg eye arm and cramping on right side, pressure behind left eye, and cramping and rib pain on right side. This report was non-serious.
Pt had syncopal episode while walking to seat following vaccination.  Heart rate between 25-40 beats per minute with low blood pressure.   IV fluids given and atropine administered to increase heart rate
A mild case of dizziness occurred 2 days after the first vaccination date.; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 28 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 21Jun2021 15:00 (Lot number: EW0217) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 23Jun2021, outcome "recovered" (24Jun2021), described as "A mild case of dizziness occurred 2 days after the first vaccination date.". The event "a mild case of dizziness occurred 2 days after the first vaccination date." was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness.  Additional Information: It was unknown whether the patient was diagnosed with COVID-19. The patient was been tested for COVID-19 since the vaccination.   No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacy student refers to a male patient of unknown age. On an unknown date in 1990s the patient was vaccinated with VARIVAX (Merck) for vaccination. No concomitant medications were reported. On an unknown date in 1990s, the patient experienced full-blown chicken pox. The outcome of full-blown chicken pox was reported as recovered/resolved on an unknown date after 2 weeks. Causality assessment was not provided. Additional information is not expected.
Information has been received from a nurse, for the Pregnancy Registry for GARDASIL, concerning a 21 year old female who on 26-JUN-2007 was received her first dose of GARDASIL, and the second dose on 11-JUN-2009, and just found out she was pregnant again. No information on status of pregnancy or whether she would continue the pregnancy. Follow up information received from a nurse concerning the patient was seen at their Clinic on 26-Jun-2007, and not again until 11-JUN-2009. On 11-JUN-2009 a urine pregnancy test was performed. And it was negative. Follow up information received from a registered nurse concerning the patient electively terminated the pregnancy for personal reasons, not related to the GARDASIL vaccination. Upon internal review abortion induced was considered an other important medical event. The patient had a history of pregnancy while on prior therapy with the 1st dose of GARDASIL (MSD, WAES#0906USA05568). No further information is available.
7 days after injection, developed extreme rash, swelling, pain  and itching around the injection site and entire upper arm, along with headache, upper GI pain, and fatigue. Symptoms continued for 5 days.  Pain did not respond to pain medication. Itch did not respond to any topical itch relief. Ice was effective. Currently day 6 of symptoms. Started on Doxycyclene 2 days ago and symptoms are now much better. Arm still red
The patient received Afluria Quadrivalent in left arm and experienced pain on her whole arm down to wrist; This spontaneous case was received on 26-Apr-2021 from other non-health professional (consumer) via Communications (reference number: SEQW21-01228) and concerned a 60-year-old, female patient.  The patient's medical history was not reported. The patient's concomitant medication included unspecified multivitamins, used for an unreported indication.   On 21-Sep-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine; dose: 0.5 ml, anatomical location: left deltoid/arm and route of administration: not reported) for influenza prophylaxis. The batch number reported was P100230210 and expiration date was 21-Jun-2021.  On an unspecified date in 2020, reported as one to two weeks after receiving Afluria Quadrivalent, the patient experienced pain on her whole arm down to wrist.  At the time of initial reporting on 26-Apr-2021, the patient had not recovered from the event of 'painful L arm'.   The patient did not provide a causality assessment.   This case is linked to cases 202102298 and 202102299 (the same reporter).  Company comment: The event of 'painful L arm' is assessed as related to Afluria Quadrivalent.; Sender's Comments: The event of 'painful L arm' is assessed as related to Afluria Quadrivalent.
Patient and father came to pharmacy for second dose of pfizer vaccine. Noted date of birth on consent form. Noted date of birth on vaccine card was different. Pharmacist confirmed verbally with the patient and father that the date of birth was as listed on vaccine card before giving vaccine and that the patient was 12 years old. Upon billing insurance there was a mismatch DOB and insurance was called. Insurance confirmed patient's correct DOB is different making him only 11 years old and not eligible for vaccination at this time. Patient was okay after vaccination.
Moderna 1/13/21, 2/8/21, 9/1/21, 4/18/22. Positive on 8/31/22.
felt miserable for days; Initial information received on 21-Oct-2021 regarding an unsolicited valid Social Media serious case received from a consumer/non-health care professional.  This case involves an 83 year old male patient who experienced felt miserable for days (feeling abnormal) after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient's vaccination included Influenza Vaccine (He got a flu shot from this late 60 year to when he turned 80 year).  The patient's medical treatment, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  In 2010, patient said he was no longer going to get the flu shot because he always felt miserable for days (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE. This event was leading to death.  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was fatal for the reported event.  It is unknown if an autopsy was done. The cause of death was reported as Feeling abnormal.  Information on the batch number to be requested.; Sender's Comments: This poorly documented social media case concerns an 83 year old male patient who had feeling abnormal and died, after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. It was unknown if an autopsy was done. Further information regarding patient's past medical condition, previous vaccination tolerance and other laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of a suspect vaccine cannot be assessed.; Reported Cause(s) of Death: felt miserable for days
Ongoing dizziness, lightheaded ness, shortness of breath.  Visit to urgent care showed no remarkable results from blood tests and CT scan of head
Onset 5 days after vaccine of hyperpigementation of skin and creases of hands and then two months later onset of nausea, anorexia, weight loss, severe dizziness and orthostatic symptoms.